Our Products
Ultraviolet Light Plasma Treatment
The first device will use UVL to inactivate germs in a patient’s plasma. The device will be used to treat blood-stream infections for which there is no known treatment, that is, no biological or pharmacological treatment available. One or more of these infections occur year-round worldwide, and cause millions of deaths, high unemployment and staggering economic losses because of the lack of specific treatments. For example, Covid-19 caused 7 million deaths worldwide. Antibiotic-resistant bloodstream infections are estimated to cause1 million deaths per year at present and by 2050, to cause 10 million death per year, worldwide, and $100 trillion economic losses per year. Fulminant bacterial infections, some viral lung infections, and infections of rare occurrence which are always or almost always fatal, i.e. Equine Encephalitis, severe West Nile Fever, Rabies, Ebola, outbreaks of infections caused by pathogens rarely affecting humans, i.e. bird flu, and infectious caused by spontaneous or intentionally mutated pathogens.
Targeted Temperature Management
The second device will provide Targeted Temperature Management (TTM) to millions of patients after cardiac arrest, traumatic brain injury and in selected patients after brain surgery by cooling and gradually re-warming the blood. Early and effective use of TTM (specifically, hypothermia) contributes to decrease disabilities and deaths.
In the US, more than 650,000 cases of cardiac arrest occur in adults per year and traumatic brain injury occurs in 50 million persons annually worldwide and costs the global economy $400 billion. In the UK it is the most common cause of death and disability under the age of 40.
Urine Cancer Screening Test
The third device will automatically prepare urine samples for examination under a microscope and will use artificial intelligence methods to identify kidney and bladder cancer cells, without human involvement. These cancers are diagnosed in 900,000 patients and cause 400,000 deaths annually. The simplicity and low cost of the procedure will allow frequent screening of the urine, like a urinalysis, and early diagnosis and treatment of these cancers.